Normal view MARC view ISBD view

Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. [electronic resource]

By:

Sanchez, S E

Contributor(s):

Producer: 20010329Description: 474-80 p. digitalISSN:

0002-9262

Subject(s):

Online resources:

Available from publisher's website

In: American journal of epidemiology vol. 153

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

to post a comment.

Back to results

1 Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.
by Leurs, Judith
2 A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation.
by Willemse, Johan L
3 A role for procarboxypepidase U (TAFI) in thrombosis.
by Willemse, Johan L
4 Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge.
by Willemse, Johan L
5 An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis.
by Heylen, Evelien
6 Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate.
by Willemse, Johan
7 Major carboxypeptidase N deficiency.
by Willemse, Johan L
8 The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays.
by Willemse, Johan L
9 Measurement of carboxypeptidase U (active thrombin-activatable fibrinolysis inhibitor) in plasma: Challenges overcome by a novel selective assay.
by Heylen, Evelien
10 Carboxypeptidase M: Multiple alliances and unknown partners.
by Deiteren, Kathleen
11 Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: development of highly selective CPU substrates as useful tools for assay development.
by Willemse, Johan L
12 Carboxypeptidase M in apoptosis, adipogenesis and cancer.
by Denis, Catherine J
13 Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma.
by Leurs, Judith
14 Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma.
by Heylen, Evelien
15 Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis.
by Mertens, Joachim C
16 Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
by Leenaerts, Dorien
17 Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
by Heylen, Evelien
18 Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
by Miljić, Predrag
19 Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke.
by Kehoe, Kaat
20 Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages.
by Matus, Valeria